V-Wave
Deborah Deutsch is an accomplished professional in global clinical affairs and safety, currently serving as the VP of Global Clinical Affairs at V-Wave since December 2020. Prior to this role, Deborah held various senior positions at Edwards Lifesciences from April 2010 to June 2020, including Sr. Director of Global Clinical Safety and Director of Clinical Affairs & Clinical Safety. Deborah's extensive experience encompasses leadership in clinical safety teams, strategic oversight in global clinical programs, and compliance in quality management at companies such as OrbusNeich Medical and Cordis Corp. Deborah holds a Bachelor of Science in Nursing from the University of Pennsylvania, earned between 1988 and 1992.
This person is not in any offices
V-Wave
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.